Press "Enter" to skip to content

New patent for Collegium Pharm drug XTAMPZA ER

0
Copyright © DrugPatentWatch. Originally published at New patent for Collegium Pharm drug XTAMPZA ER

Annual Drug Patent Expirations for XTAMPZA+ER
Annual Drug Patent Expirations for XTAMPZA+ER

Xtampza Er is a drug marketed by Collegium Pharm Inc and is included in one NDA. It is available from two suppliers. There are fourteen patents protecting this drug and one Paragraph IV challenge.

XTAMPZA ER drug price trends.

Drug patent litigation for XTAMPZA ER.

This drug has seventeen patent family members in eleven countries.

The generic ingredient in XTAMPZA ER is oxycodone. Two suppliers are listed for this compound. Additional details are available on the oxycodone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Collegium Pharm drug XTAMPZA ER
    Do NOT follow this link or you will be banned from the site!